REGENERON PHARMACEUTICALS, INC.: accounts_payable
| Value | {"amount": 789500000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2024-12-31) |
| Status | current |
| Entity | REGENERON PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:39:12.123968+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/fdf69a13-5dbc-4441-b676-77a9da94d506
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001804220-25-000011Retrieved: 2026-08-19T08:39:12.123968+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000872589/accounts-payable/2024-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/fdf69a13-5dbc-4441-b676-77a9da94d506
History
- no predecessors — first report